miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis

CE Condrat, DC Thompson, MG Barbu, OL Bugnar… - Cells, 2020 - mdpi.com
MicroRNAs (miRNAs) represent a class of small, non-coding RNAs with the main roles of
regulating mRNA through its degradation and adjusting protein levels. In recent years …

Biomarkers of aging: from function to molecular biology

KH Wagner, D Cameron-Smith, B Wessner, B Franzke - Nutrients, 2016 - mdpi.com
Aging is a major risk factor for most chronic diseases and functional impairments. Within a
homogeneous age sample there is a considerable variation in the extent of disease and …

MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications

JA Slota, SA Booth - Non-coding RNA, 2019 - mdpi.com
The central nervous system can respond to threat via the induction of an inflammatory
response. Under normal circumstances this response is tightly controlled, however …

microRNAs in Parkinson's disease: from pathogenesis to novel diagnostic and therapeutic approaches

L Leggio, S Vivarelli, F L'Episcopo, C Tirolo… - International journal of …, 2017 - mdpi.com
Parkinson's disease (PD) is the most prevalent central nervous system (CNS) movement
disorder and the second most common neurodegenerative disease overall. PD is …

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

KS Sheinerman, JB Toledo, VG Tsivinsky… - Alzheimer's research & …, 2017 - Springer
Background Minimally invasive specific biomarkers of neurodegenerative diseases (NDs)
would facilitate patient selection and disease progression monitoring. We describe the …

Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases

C Barbagallo, G Mostile, G Baglieri, F Giunta… - Cellular and Molecular …, 2020 - Springer
Neurodegenerative diseases (NDs) are age-dependent; among them, Alzheimer's disease
(AD) and Parkinson's disease (PD) are the most frequent. Similarly, cerebrovascular …

MicroRNA alteration, application as biomarkers, and therapeutic approaches in neurodegenerative diseases

TPN Nguyen, M Kumar, E Fedele, G Bonanno… - International journal of …, 2022 - mdpi.com
MicroRNAs (miRNAs) are essential post-transcriptional gene regulators involved in various
neuronal and non-neuronal cell functions and play a key role in pathological conditions …

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

ZG Lu, J Shen, J Yang, JW Wang, RC Zhao… - … and Targeted Therapy, 2023 - nature.com
Nucleic acid drugs have the advantages of rich target selection, simple in design, good and
enduring effect. They have been demonstrated to have irreplaceable superiority in brain …

Body fluid biomarkers for Alzheimer's disease—an up-to-date overview

AF Bălașa, C Chircov, AM Grumezescu - Biomedicines, 2020 - mdpi.com
Neurodegeneration is a highly complex process which is associated with a variety of
molecular mechanisms related to ageing. Among neurodegenerative disorders, Alzheimer's …

Early biomarkers of neurodegenerative and neurovascular disorders in diabetes

A Gasecka, D Siwik, M Gajewska… - Journal of Clinical …, 2020 - mdpi.com
Diabetes mellitus (DM) is a common disease worldwide. There is a strong association
between DM and neurovascular and neurodegenerative disorders. The first group mainly …